Supernus Pharmaceuticals, Inc.
SUPN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $151,371 | $144,711 | $115,848 | $69,331 |
| Short-Term Investments | $129,789 | $377,885 | $347,742 | $384,281 |
| Receivables | $171,254 | $140,831 | $145,640 | $142,077 |
| Inventory | $79,399 | $44,023 | $49,423 | $54,293 |
| Other Curr. Assets | $0 | $31,416 | $28,931 | $36,088 |
| Total Curr. Assets | $593,891 | $738,866 | $687,584 | $686,070 |
| Property Plant & Equip (Net) | $10,627 | $11,069 | $11,338 | $11,545 |
| Goodwill | $119,080 | $117,019 | $117,019 | $117,019 |
| Intangibles | $623,481 | $481,307 | $502,126 | $521,912 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $6,181 | $0 | $0 |
| Other NC Assets | $72,675 | $27,963 | $29,223 | $31,527 |
| Total NC Assets | $825,863 | $643,539 | $659,706 | $682,003 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,419,754 | $1,382,405 | $1,347,290 | $1,368,073 |
| Liabilities | – | – | – | – |
| Payables | $108,613 | $8,215 | $7,072 | $4,587 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $222,016 | $48,168 | $52,344 | $68,565 |
| Total Curr. Liab. | $330,629 | $286,360 | $281,772 | $292,397 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $981 | $4,961 |
| Other NC Liab. | $8,036 | $7,762 | $7,464 | $7,600 |
| Total NC Liab. | $39,458 | $32,145 | $34,813 | $39,943 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $31,422 | $31,774 | $32,305 | $34,271 |
| Total Liabilities | $370,087 | $318,505 | $316,585 | $332,340 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $57 | $56 | $56 | $56 |
| Retained Earnings | $521,981 | $567,098 | $544,599 | $556,426 |
| AOCI | -$71 | -$200 | -$159 | -$189 |
| Other Equity | -$0 | $0 | $0 | $0 |
| Total Equity | $1,049,667 | $1,063,900 | $1,030,705 | $1,035,733 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,419,754 | $1,382,405 | $1,347,290 | $1,368,073 |
| Net Debt | -$151,371 | -$144,711 | -$115,848 | -$69,331 |